Platelet Surface CD62P and CD63, Mean Platelet Volume, and Soluble/Platelet P-Selectin as Indexes of Platelet Function in Atrial Fibrillation. A Comparison of "Healthy Control Subjects" and "Disease Control Subjects" in Sinus Rhythm

Journal of the American College of Cardiology

Volumn 49, Issue 19, 2007, Pages 1957-1964

  Choudhury, Anirban ^a   Chung, Irene ^a   Blann, Andrew D ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD63 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN; WARFARIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG SUBSTITUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE VOLUME; THROMBOSIS;

AGED; ANTICOAGULANTS; ANTIGENS, CD; ASPIRIN; ATRIAL FIBRILLATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEINS; WARFARIN;

EID: 34247866352     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.038     Document Type: Article

References (51)

1. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
2. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomised controlled trials. Arch Intern Med 154 (1994) 1449-1457
3. Lip G.Y.H. The prothrombotic state in atrial fibrillation: the atrium, the endothelium ... and tissue factor?. Thromb Res 111 (2003) 133-135
4. Blann A.D. Angiogenesis and platelets: the clot thickens further. Cardiovasc Res 63 (2004) 192-193
5. Kestin A.S., Ellis P.A., Barnard M.R., Errichetti A., Rosner B.A., and Michelson A.D. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 88 (1993) 1502-1511
6. Schmitz G., Rothe G., Ruf A., et al. European Working Group on Clinical Cell Analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79 (1998) 885-896
7. Feinberg W.M., Pearce L.A., Hart R.G., et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 30 (1999) 2547-2553
8. Gustafsson C., Blomback M., Britton M., Hamsten A., and Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 21 (1990) 47-51
9. Lip G.Y., Lip P.L., Zarifis J., et al. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94 (1996) 425-431
10. Minamino T., Kitakaze M., Sanada S., et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 98 (1998) 1721-1727
11. Yamauchi K., Furui H., Taniguchi N., and Sotobata I. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 27 (1986) 481-487
12. Furui H., Taniguchi N., Yamauchi K., Sotobata I., Saito H., and Inagaki H. Effects of treadmill exercise on platelet function, blood coagulability and fibrinolytic activity in patients with atrial fibrillation. Jpn Heart J 28 (1987) 177-184
13. Li-Saw-Hee F.L., Blann A.D., Gurney D., and Lip G.Y. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 22 (2001) 1741-1747
14. Conway D.S., Pearce L.A., Chin B.S., Hart R.G., and Lip G.Y. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 106 (2002) 1962-1967
15. Kamath S., Blann A.D., Caine G.J., Gurney D., Chin B.S., and Lip G.Y. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation. Stroke 33 (2002) 1237-1242
16. Coban E., Yazicioglu G., Berkant Avci A., and Akcit F. The mean platelet volume in patients with essential and white coat hypertension. Platelets 16 (2005) 435-438
17. Henning B.F., Zidek W., Linder B., and Tepel M. Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res 25 (2002) 103-108
18. Tan K.T., Tayebjee M.H., Macfadyen R.J., Lip G.Y., and Blann A.D. Elevated platelet microparticles in stable coronary disease are unrelated to disease severity or to indices of inflammation. Platelets 16 (2005) 368-371
19. Gage B.F., Waterman A.D., Shanon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
20. Fuster V., Rydén L.E., Cannon D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
21. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med 8 (2002) 1227-1234
22. Heppell R.M., Berkin K.E., McLenachan J.M., and Davies J.A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 77 (1997) 407-411
23. Pongratz G., Brandt-Pohlmann M., Henneke K.H., et al. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 111 (1997) 929-933
24. Vene N., Mavri A., Kosmelj K., and Stegnar M. High d-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulation therapy. Thromb Haemost 90 (2003) 1163-1172
25. Lip G.Y.H., and Edwards S.J. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 118 (2006) 321-333
26. Connolly S., Pogue J., Hart R., et al., ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367 (2006) 1903-1912
27. Inui Y., Suehiro T., Kumon Y., and Hashimoto K. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus. J Atheroscler Thromb 1 (1994) 108-112
28. Nadar S.K., Lip G.Y., and Blann A.D. Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project. Thromb Haemost 92 (2004) 1342-1348
29. Endler G., Klimesch A., Sunder-Plassmann H., et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117 (2002) 399-404
30. Glud T., Schmidt E.B., Kristensen S.D., and Arnfred T. Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand 220 (1986) 401-405
31. Huczek Z., Kochman J., Filipiak K.J., et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 46 (2005) 284-290
32. Yang A., Pizzulli L., and Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117 (2006) 371-377
33. Papanas N., Symeonidis G., Maltezos E., et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15 (2004) 475-478
34. Bath P., Algert C., Chapman N., Neal B., and PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35 (2004) 622-626
35. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., and Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?. Stroke 35 (2004) 1688-1691
36. Schick P.K., Konkle B.A., He X., and Thornton R.D. P-selectin mRNA is expressed at a later phase of megakaryocyte maturation than mRNAs for von Willebrand factor and glycoprotein Ib-alpha. J Lab Clin Med 121 (1993) 714-721
37. Johnston G.I., Cook R.G., and McEver R.P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56 (1989) 1033-1044
38. Semenov A.V., Romanov Y.A., Loktionova S.A., et al. Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Mosc) 64 (1999) 1326-1335
39. Ferroni P., Pulcinelli F.M., Lenti L., and Gazzaniga P.P. Is soluble P selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis?. Thromb Haemost 81 (1999) 472-473
40. Ferroni P., Speziale G., Ruvolo G., et al. Correlation between platelet activation and inflammatory response during hypothermic cardiopulmonary bypass. Thromb Haemost 80 (1998) 58-64
41. Kostelijk E.H., Fijnheer R., Nieuwenhuis H.K., Gouwerok C.W., and de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 76 (1996) 1086-1089
42. Kameda H., Morita I., Handa M., et al. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. Br J Haematol 97 (1997) 348-355
43. Khew-Goodall Y., Butcher C.M., Litwin M.S., et al. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 87 (1996) 1432-1438
44. Gotsch U., Jager U., Dominis M., and Vestweber D. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun 2 (1994) 7-14
45. Gurbel P.A., Kereiakes D.J., and Serebruany V.L. Soluble selectin is not a surrogate marker for platelet P selectin: evidence from a multicentre chest pain study group. J Thromb Thrombolysis 10 (2000) 15-22
46. Serebruany V.L., and Gurbel P.A. Assessment of platelet activity by measuring platelet derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. Thromb Res 93 (1999) 149-150
47. Michelson A.D., Barnard M.R., Hechtman H.B., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly loose surface P selectin, but continue to circulate and function. Proc Natl Acad Sci U S A 93 (1996) 11877-11882
48. Li N., Wallen N.H., and Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 100 (1999) 1374-1379
49. O'Connor C.M., Gurbel P.A., and Serebruany V.L. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol 83 (1999) 1345-1349
50. Jilma B., Blann A., Pernerstorfer T., et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med 159 (1999) 857-863
51. Goette A., Ittenson A., Hoffmanns P., et al. Increased expression of P-selectin in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1872-1875